Lido Advisors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.23M | Buy |
19,146
+916
| +5% | +$253K | 0.01% | 542 |
|
|
2026
Q1 | $5.39M | Buy |
18,230
+1,529
| +9% | +$454K | 0.02% | 441 |
|
|
2025
Q4 | $4.53M | Buy |
16,701
+354
| +2% | +$96.2K | 0.01% | 488 |
|
|
2025
Q3 | $4.42M | Buy |
16,347
+5,764
| +54% | +$1.57M | 0.01% | 472 |
|
|
2025
Q2 | $2.92M | Buy |
10,583
+4,155
| +65% | +$1.13M | 0.01% | 496 |
|
|
2025
Q1 | $1.71M | Buy |
6,428
+565
| +10% | +$139K | 0.01% | 585 |
|
|
2024
Q4 | $1.4M | Buy |
5,863
+320
| +6% | +$73.6K | 0.01% | 632 |
|
|
2024
Q3 | $1.22M | Sell |
5,543
-6
| -0.1% | -$1.24K | 0.01% | 631 |
|
|
2024
Q2 | $1.09M | Buy |
5,549
+495
| +10% | +$102K | 0.01% | 631 |
|
|
2024
Q1 | $1.09M | Buy |
5,054
+263
| +5% | +$55.2K | 0.01% | 619 |
|
|
2023
Q4 | $1.03M | Buy |
4,791
+502
| +12% | +$107K | 0.01% | 608 |
|
|
2023
Q3 | $859K | Sell |
4,289
-16,257
| -79% | -$3.23M | 0.01% | 587 |
|
|
2023
Q2 | $3.81M | Buy |
20,546
+4,424
| +27% | +$818K | 0.03% | 260 |
|
|
2023
Q1 | $3.09M | Buy |
16,122
+10,425
| +183% | +$1.89M | 0.03% | 262 |
|
|
2022
Q4 | $958K | Buy |
5,697
+654
| +13% | +$114K | 0.01% | 420 |
|
|
2022
Q3 | $892K | Sell |
5,043
-16
| -0.3% | -$3.16K | 0.01% | 397 |
|
|
2022
Q2 | $1.03M | Buy |
5,059
+1,612
| +47% | +$342K | 0.01% | 343 |
|
|
2022
Q1 | $819K | Buy |
3,447
+1,540
| +81% | +$362K | 0.01% | 448 |
|
|
2021
Q4 | $435K | Buy |
1,907
+553
| +41% | +$122K | ﹤0.01% | 664 |
|
|
2021
Q3 | $261K | Buy |
1,354
+345
| +34% | +$69.9K | ﹤0.01% | 791 |
|
|
2021
Q2 | $215K | Buy |
1,009
+6
| +0.6% | +$1.27K | ﹤0.01% | 846 |
|
|
2021
Q1 | $205K | Buy |
+1,003
| New | +$198K | ﹤0.01% | 801 |
|
|
2020
Q2 | – | Sell |
-4,972
| Closed | -$860K | – | 616 |
|
|
2020
Q1 | $860K | Buy |
4,972
+513
| +12% | +$102K | 0.04% | 250 |
|
|
2019
Q4 | $895K | Buy |
4,459
+795
| +22% | +$163K | 0.04% | 282 |
|
|
2019
Q3 | $774K | Sell |
3,664
-57
| -2% | -$11.9K | 0.04% | 256 |
|
|
2019
Q2 | $722K | Sell |
3,721
-1,014
| -21% | -$187K | 0.04% | 240 |
|
|
2019
Q1 | $779K | Buy |
4,735
+2,004
| +73% | +$354K | 0.05% | 226 |
|
|
2018
Q4 | $513K | Buy |
2,731
+185
| +7% | +$34.2K | 0.05% | 225 |
|
|
2018
Q3 | $433K | Buy |
2,546
+401
| +19% | +$67.5K | 0.04% | 270 |
|
|
2018
Q2 | $351K | Sell |
2,145
-2,630
| -55% | -$430K | 0.04% | 274 |
|
|
2018
Q1 | $772K | Buy |
4,775
+1,626
| +52% | +$259K | 0.11% | 127 |
|
|
2017
Q4 | $459K | Sell |
3,149
-1,154
| -27% | -$164K | 0.07% | 163 |
|
|
2017
Q3 | $590K | Buy |
+4,303
| New | +$544K | 0.09% | 129 |
|
Other funds holding CME
Lido Advisors's CME Position: Q2 2026 in Review
Lido Advisors increased its CME Group (CME) stake by 5% in Q2 2026, buying an estimated $253K and bringing the position to 19,146 shares worth $4.23M. The position accounts for 0.01% of the portfolio, ranked #542.
Lido Advisors first reported a position in CME in Q3 2017 and has held it in 33 quarters since. The position peaked at $5.39M in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Lido Advisors held 19,146 shares of CME Group worth $4.23M as of Q2 2026.
- Lido Advisors bought 916 CME Group shares in Q2 2026, an estimated $253K.
- CME Group made up 0.01% of Lido Advisors's portfolio in Q2 2026, its #542 holding.
- Lido Advisors first reported a position in CME Group in Q3 2017 and has held it in 33 quarters since.
- Lido Advisors's CME Group position peaked at $5.39M in Q1 2026.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.